A multicenter, randomized, open label comparison of azithromycin and amoxicillin/clavulanate in acute otitis media among children attending day care or school

Pediatric Infectious Disease Journal

Volumn 15, Issue 9 SUPPL., 1996, Pages

  Khurana, Chandra Mohini ^a,b  

^a ADVOCATE ILLINOIS MASONIC MEDICAL CENTER   (United States)

^b St Francis Hospital   (United States)

Author keywords

amoxicillin clavulanate; Azithromycin; compliance; day care; otitis media

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAY CARE; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; OTITIS MEDIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN TOXICITY;

ACUTE DISEASE; AMOXICILLIN; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHILD; CHILD DAY CARE CENTERS; CHILD, PRESCHOOL; CLAVULANIC ACIDS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFANT; MALE; OTITIS MEDIA; SCHOOLS;

EID: 0029816075     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199609000-00001     Document Type: Article

References (30)

1. Baker RC. Pitfalls in diagnosing acute otitis media. Pediatr Ann 1991;20:591-8.
2. Bergus GR. Staving off acute otitis media: when is prophylaxis with antibiotics desirable? Postgrad Med 1991;90:99-106.
3. Teele DW, Klein JO, Rosner B, et al. Middle ear disease and the practice of pediatrics: burden during the first five years of life. JAMA 1983;249:1026-9.
4. Foulds G, Shepard RM, Johnson RB. The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother 1990;25(Suppl A):73-82.
5. Gladue RP, Bright GM, Isaacson RE, Newborg MF. In vitro and in vivo uptake of azithromycin (CP-62 993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob Agents Chemother 1989;33:277-82.
6. Retsema J, Girard A, Schelkly W, et al. Spectrum and mode of action of azithromycin (CP-62 993), a new 15-membered-ring macrolide with improved potency against Gram-negative organisms. Antimicrob Agents Chemother 1987;31:1939-47.
7. Hardy DJ, Hensey DM, Beyer JM, Vojtko C, McDonald EJ, Fernandes PB. Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides. Antimicrob Agents Chemother 1988;32:1710-19.
8. Dunkin KT, Jones S, Howard AJ. The in vitro activity of CP-62 993 against Haemophilus Influenzae, Branhamella catarrhalis, staphylococci and streptococci. J Antimicrob Chemother 1988;21:405-11.
9. Drew RH, Gallis HA. Azithromycin-spectrum of activity, pharmacokinetics, and clinical applications. Pharmacotherapy 1992;12:161-73.
10. Peters DH, Friedel HA, McTavish D. Azithromycin: a review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy. Drugs 1992;44:750-99.
11. Manfredi R, Jannuzzi C, Mantero E, et al. Clinical comparative study of azithromycin versus erythromycin in the treatment of acute respiratory tract infections in children. J Chemother 1992;4:364-70.
12. Daniel RR. Comparison of azithromycin and co-amoxiclav in the treatment of otitis media in children. J Antimicrob Chemother 1993;31(Suppl E):65-71.
13. Schaad UB. Multicentre evaluation of azithromycin in comparison with co-amoxiclav for the treatment of acute otitis media in children. J Antimicrob Chemother 1993;31(Suppl E):81-8.
14. Mohs E, Rodriguez-Solares A, Rivas E, El Hoshy Z. A comparative study of azithromycin and amoxycillin in paediatric patients with acute otitis media. J Antimicrob Chemother 1993;31(Suppl E):73-9.
15. Aronovitz G. A multicenter, open label trial of azithromycin vs. amoxicillin/clavulanate for the management of acute otitis media in children. Pediatr Infect Dis J 1996;15:S15-9.
16. McLinn S. A multicenter, double blind comparison of azithromycin and amoxicillin/clavulanate for the treatment of acute otitis media in children. Pediatr Infect Dis J 1996;15:S20-30.
17. McCarty J. A multicenter, open label trial of azithromycin for the treatment of children with acute otitis media. Pediatr Infect Dis J 1996;15:S10-14.
18. Bergman AR, Werner RJ. Failure of children to receive penicillin by mouth. N Engl J Med 1963;268:1334-8.
19. Charney E, Bynum R, Eldredge D, et al. How well do patients take oral penicillin: a collaborative study in private practice. Pediatrics 1967;40:188-95.
20. Cockburn J, Gibberd RW, Reid AL, Sanson-Fisher RW. Determinants of non-compliance with short term antibiotic regimens. Br Med J 1987;295:814-8.
21. Chater RW. Pediatric dosing: tips for tots. Am Pharm May 1993;NS33:55-6.
22. Klein JO. Selection of oral antimicrobial agents for otitis media and pharyngitis. Infect Dis Clin Pract 1994;3:151-7.
23. Dagan R, Shvartzman P, Liss Z. Variation in acceptance of common oral antibiotic suspensions. Pediatr Infect Dis J 1994;13:686-90.
24. Chow AW, Hall CB, Klein JO, Kammer RB, Meyer RD, Remington JS. General guidelines for the evaluation of new anti-infective drugs for the treatment of respiratory tract infections: evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Clin Infect Dis 1992;15(Suppl 1):S62-88.
25. Pichichero ME. Therapeutic considerations for management of otitis media, sinusitis, and tonsillopharyngitis. Pediatr Asthma Allergy Immunol 1992;6:167-74.
26. Lisby-Sutch SM, Nemec-Dwyer MA, Deeter RG, Gaur SM. Therapy of otitis media. Clin Pharm 1990;9:15-34.
27. True BL, Helling DK. Dilemmas in primary care: antibiotic treatment of acute otitis media. Drug Intell Clin Pharm 1986;20:666-9.
28. Schentag JJ, Ballow CH. Tissue-directed pharmacokinetics. Am J Med 1991;91(Suppl 3A):3A-5S-3A-11S.
29. Retsema JA, Bergeron JM, Girard D, Milisen WB, Girard AE. Preferential concentration of azithromycin in an infected mouse thigh model. J Antimicrob Chemother 1993;31(Suppl E):5-16.
30. Girard AE, Cimochowski CR, Faiella JA. The unique pharmacokinetics of azithromycin in the gerbil model of middle ear infection [Abstract A64]. In: Program and abstracts of the 91st general meeting of the American Society for Microbiology. Washington, DC: Books International, 1991:11.